NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 178 filers reported holding NXSTAGE MEDICAL INC in Q3 2018. The put-call ratio across all filers is 1.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,000 | 0.0% | 141 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 141 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | +150.0% | 141 | +23.7% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 114 | +119.2% | 0.00% | – |
| Q4 2017 | $2,000 | -75.0% | 52 | -86.4% | 0.00% | – |
| Q2 2016 | $8,000 | +33.3% | 383 | -3.5% | 0.00% | – |
| Q1 2016 | $6,000 | -25.0% | 397 | +3.7% | 0.00% | – |
| Q4 2015 | $8,000 | +33.3% | 383 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | +20.0% | 383 | +3.5% | 0.00% | – |
| Q2 2015 | $5,000 | +66.7% | 370 | +84.1% | 0.00% | – |
| Q1 2015 | $3,000 | -25.0% | 201 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | -42.9% | 201 | -59.9% | 0.00% | – |
| Q3 2014 | $7,000 | 0.0% | 501 | 0.0% | 0.00% | – |
| Q2 2014 | $7,000 | +133.3% | 501 | +149.3% | 0.00% | – |
| Q1 2014 | $3,000 | – | 201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 2,721,906 | $73,029,000 | 11.38% |
| DAFNA Capital Management LLC | 216,119 | $5,798,000 | 4.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,744,151 | $100,456,000 | 3.87% |
| KOPP INVESTMENT ADVISORS LLC | 117,779 | $3,160,000 | 3.09% |
| Perceptive Advisors | 1,818,189 | $48,782,000 | 2.78% |
| Pennant Capital Management, LLC | 1,927,408 | $51,712,000 | 2.45% |
| GILDER GAGNON HOWE & CO LLC | 4,955,630 | $132,960,000 | 2.24% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $7,378,000 | 2.18% |
| Portolan Capital Management | 545,032 | $14,623,000 | 1.90% |
| Tamarack Advisers, LP | 110,000 | $2,951,000 | 1.84% |